Holberg EEG

Holberg EEG occupies a focused position at the intersection of clinical neurodiagnostics, structured medical data, and applied AI. Rather than competing as a general-purpose healthcare analytics vendor, it concentrates on EEG reporting workflows and the conversion of narrative examinations into standardized, machine-readable data. hiSCORE addresses reporting consistency, while SCORE-AI and autoSCORE extend the platform toward automated interpretation and clinical decision support. Its potential differentiation comes from combining a large annotated EEG collection with domain-specific reporting standards and clinical expertise originating from a Haukeland University Hospital spin-off. The available company record does not identify distinct named competitors, so direct market-share or feature comparisons should be treated cautiously. Natus Medical’s acquisition on Sep 30, 2025 materially changed Holberg EEG’s competitive context: the technology is now part of a broader neurodiagnostics organization rather than an independent early-stage software company.

Holberg EEG’s trajectory shows a long product-development cycle followed by strategic consolidation. Founded in 2009, the company raised NOK 5.6 million, equivalent to approximately $685,881, in a single venture round led by TeleVenture Management on Sep 11, 2015. Its product scope subsequently expanded from structured EEG reporting into a broader workflow: hiSCORE supports standardized reporting and database management, autoSCORE provides AI-assisted classification, SCORE-AI targets automated routine EEG interpretation, and the SCORE Educational Platform supports clinician training. The company’s technical foundation is a structured, highly annotated EEG dataset intended to support machine-learning development and future predictive analysis. The clearest inflection point came on Sep 30, 2025, when Natus Medical acquired Holberg EEG; the company was subsequently marked closed, indicating that it is no longer operating as an independent entity.